glp 1 and stimulants Mechanisms of GLP-1 in Modulating Craving Addiction: Neurobiological and Translational Insights When the Breakthrough Obesity G-Agonist

Objective To determine whether the use of glucagon-like peptide-1 (GLP-1) receptor agonists is associated with an increased risk of suicidal ideation, self-harm, and suicide among patients with type 2 diabetes compared with the use of dipeptidyl peptidase-4 (DPP-4) inhibitors or sodium-glucose cotransporter-2 (SGLT-2) inhibitors

without talking to a doctor or sharing medical records

Canadian study reveals diabetic patients taking GLP-1 medications face twice the risk of eye problems, with longer exposure increasing danger of macular degeneration.

Can weight loss injections cause seizures

GLP-1 Studio is an advocacy media production platform focused on GLP-1 education, access, and self-advocacy

This update elevates obesity within the global noncommunicable disease agenda and sets a clear mandate for action